Anixa Biosciences (ANIX) Short Interest Ratio & Short Volume $3.08 -0.05 (-1.60%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Anixa Biosciences Short Interest DataAnixa Biosciences (ANIX) has a short interest of 421,900 shares, representing 1.38% of the float (the number of shares available for trading by the public). This marks a -28.94% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.6, indicating that it would take 5.6 days of the average trading volume of 124,875 shares to cover all short positions.Current Short Interest421,900 sharesPrevious Short Interest593,700 sharesChange Vs. Previous Month-28.94%Dollar Volume Sold Short$1.48 millionShort Interest Ratio5.6 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares32,180,000 sharesFloat Size30,550,000 sharesShort Percent of Float1.38%Today's Trading Volume110,408 sharesAverage Trading Volume124,875 sharesToday's Volume Vs. Average88% Short Selling Anixa Biosciences? Sign up to receive the latest short interest report for Anixa Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartANIX Short Interest Over TimeANIX Days to Cover Over TimeANIX Percentage of Float Shorted Over Time Ad Golden CrestBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide Anixa Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024421,900 shares $1.48 million -28.9%1.4%5.6 $3.50 10/15/2024593,700 shares $1.80 million -5.3%1.9%9 $3.03 9/30/2024627,200 shares $1.98 million -8.9%2.1%6.5 $3.15 9/15/2024688,800 shares $2.31 million -3.2%2.3%7.1 $3.35 8/31/2024711,600 shares $2.38 million +1.4%2.3%7.2 $3.34 8/15/2024701,800 shares $2.24 million +0.1%2.3%6.7 $3.19 Get the Latest News and Ratings for ANIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024701,000 shares $2.33 million +33.0%2.3%6.7 $3.32 7/15/2024526,900 shares $1.70 million -2.1%1.7%4.8 $3.22 6/30/2024538,200 shares $1.19 million -5.0%1.8%6.6 $2.21 6/15/2024566,200 shares $1.48 million +3.2%1.9%6.5 $2.61 5/31/2024548,500 shares $1.33 million -1.1%1.8%5.1 $2.43 5/15/2024554,300 shares $1.62 million -12.3%1.8%5 $2.93 4/30/2024632,100 shares $1.88 million +14.3%2.1%5.3 $2.97 4/15/2024553,100 shares $1.75 million -4.0%1.8%4.6 $3.16 3/31/2024575,900 shares $1.80 million -3.6%1.9%4 $3.12 3/15/2024597,200 shares $2.20 million -3.4%2.0%3.9 $3.69 2/29/2024618,200 shares $2.16 million +8.2%2.1%2.9 $3.50 2/15/2024571,500 shares $2.33 million -16.1%1.9%2.7 $4.08 1/31/2024681,500 shares $3.09 million +1.6%2.3%3.4 $4.54 1/15/2024670,900 shares $2.95 million +10.7%2.2%3.7 $4.39 12/31/2023606,100 shares $2.35 million -8.4%2.1%3.9 $3.88 12/15/2023661,500 shares $2.48 million +14.2%2.2%4.7 $3.75 11/30/2023579,200 shares $1.93 million -1.6%2.0%5 $3.34 11/15/2023588,400 shares $1.69 million -1.2%2.0%12.7 $2.88 10/31/2023595,500 shares $1.88 million -7.7%2.0%12.7 $3.16 10/15/2023645,300 shares $2.16 million +6.1%2.2%12.4 $3.34 9/30/2023608,100 shares $1.99 million -6.0%2.1%7.7 $3.27 9/15/2023647,000 shares $2.12 million +3.3%2.2%8.3 $3.28 8/31/2023626,500 shares $2.30 million -4.0%2.1%8.1 $3.67 8/15/2023652,600 shares $2.41 million -1.6%2.2%8 $3.69 7/31/2023663,000 shares $2.38 million -6.0%2.3%7.5 $3.59 7/15/2023705,300 shares $2.57 million +15.2%2.4%7.4 $3.64 6/30/2023612,400 shares $1.96 million +0.7%2.1%5.7 $3.20 6/15/2023608,400 shares $2.07 million -3.6%2.1%6.6 $3.41 5/31/2023630,800 shares $1.93 million +0.9%2.1%6.5 $3.06 5/15/2023624,900 shares $2.16 million +4.2%2.1%6.3 $3.45 4/30/2023599,500 shares $2.45 million +2.3%2.0%6.4 $4.08 4/15/2023586,200 shares $3.50 million +6.9%2.0%7.3 $5.97 3/31/2023548,300 shares $2.36 million +1.2%1.9%9.5 $4.30 3/15/2023541,600 shares $2.26 million -5.6%1.8%10.2 $4.18JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/28/2023573,600 shares $2.54 million -3.1%1.9%12.2 $4.42 2/15/2023592,000 shares $2.46 million +0.8%2.0%13.6 $4.16 1/31/2023587,300 shares $2.57 million -1.1%2.0%13.2 $4.37 1/15/2023594,000 shares $2.97 million +0.2%2.0%11.9 $5.00 12/30/2022592,700 shares $2.52 million -1.9%2.0%11.7 $4.25 12/15/2022604,400 shares $2.51 million -2.0%2.1%8.7 $4.15 11/30/2022616,600 shares $3.11 million -1.0%2.1%6.8 $5.04 11/15/2022622,500 shares $3.12 million -3.1%2.1%6.8 $5.01 10/31/2022642,600 shares $3.60 million -1.3%2.2%6.8 $5.60 10/15/2022650,800 shares $3.14 million +23.9%2.2%7 $4.82 9/30/2022525,400 shares $2.58 million +15.0%1.8%5.5 $4.92 9/15/2022457,000 shares $2.05 million -2.2%1.6%5.5 $4.48 8/31/2022467,200 shares $1.95 million -5.4%1.6%7.5 $4.17 8/15/2022493,600 shares $2.25 million +3.2%1.7%5.9 $4.55 7/31/2022478,100 shares $1.82 million +0.7%1.7%5.6 $3.80 7/15/2022475,000 shares $1.36 million -0.5%1.6%5.1 $2.86 6/30/2022477,400 shares $1.46 million -4.0%1.7%5.3 $3.06 6/15/2022497,500 shares $1.58 million -2.9%1.7%5.6 $3.17 5/31/2022512,500 shares $1.84 million +1.3%1.8%6 $3.59 5/15/2022505,700 shares $1.70 million -12.4%1.8%7.2 $3.37 4/30/2022577,400 shares $1.88 million -10.3%2.0%8.5 $3.25 4/15/2022643,400 shares $1.69 million -4.1%2.2%10.5 $2.62 3/31/2022671,200 shares $1.84 million -0.9%2.3%9 $2.74 3/15/2022677,000 shares $1.69 million +0.1%2.4%7.4 $2.50 2/28/2022676,200 shares $1.88 million -2.7%2.4%5.4 $2.78 2/15/2022695,200 shares $2.18 million -4.2%2.4%5 $3.13 1/31/2022725,800 shares $2.38 million -3.2%2.5%4.9 $3.28 1/15/2022749,800 shares $2.56 million +5.2%2.6%4.5 $3.41 12/31/2021712,900 shares $2.12 million +0.5%2.5%4.4 $2.97 12/15/2021709,200 shares $2.23 million +10.1%2.5%4.6 $3.14 11/30/2021644,000 shares $2.34 million -1.0%2.3%4.3 $3.64 11/15/2021650,800 shares $2.96 million -4.2%2.3%2.9 $4.55 10/29/2021679,400 shares $3.24 million +4.2%2.4%2.8 $4.77 10/15/2021652,100 shares $2.86 million +0.1%2.3%2.6 $4.39 9/30/2021651,500 shares $3.11 million -8.1%2.3%2.3 $4.77 9/15/2021708,800 shares $3.41 million -12.7%2.5%2.5 $4.81 8/31/2021812,200 shares $4.55 million +12.7%2.9%2.9 $5.60 8/13/2021720,600 shares $2.99 million -0.1%2.5%4.1 $4.15 7/30/2021721,500 shares $3.19 million -8.7%2.5%4.2 $4.42 7/15/2021790,000 shares $3.22 million +25.1%2.8%4.9 $4.07 6/30/2021631,400 shares $2.45 million -3.8%2.2%3.3 $3.88 6/15/2021656,400 shares $2.78 million -14.9%2.3%2.5 $4.23 5/28/2021771,400 shares $3.06 million -3.5%2.7%1.4 $3.97 5/14/2021799,600 shares $2.77 million -0.5%N/A1.4 $3.46 4/30/2021803,600 shares $3.83 million +51.9%N/A1.4 $4.77 4/15/2021529,100 shares $2.43 million -18.7%N/A0.8 $4.60 3/31/2021650,500 shares $3.17 million +15.0%N/A1 $4.87 3/15/2021565,500 shares $3.30 million +13.6%N/A0.8 $5.84 2/26/2021497,700 shares $2.58 million +3.9%N/A0.7 $5.18 2/12/2021479,200 shares $2.54 million -15.2%N/A0.7 $5.31JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/29/2021564,900 shares $2.03 million -38.2%N/A0.8 $3.60 1/15/2021914,600 shares $4.01 million -17.6%N/A1.4 $4.38 12/31/20201,110,000 shares $3.54 million +53.8%N/A1.9 $3.19 12/15/2020721,700 shares $1.90 million -21.3%N/A1.3 $2.63 11/30/2020916,500 shares $2.55 million +2.6%N/A4.8 $2.78 11/15/2020893,100 shares $1.94 million -22.3%N/A3.9 $2.17 10/30/20201,150,000 shares $2.40 million -14.2%N/A4.9 $2.09 10/15/20201,340,000 shares $3.77 million -12.4%N/A5.1 $2.81 9/30/20201,530,000 shares $3.72 million +0.7%N/A4.9 $2.43 9/15/20201,520,000 shares $3.51 million +11.0%N/A4.6 $2.31 ANIX Short Interest - Frequently Asked Questions What is Anixa Biosciences' current short interest? Short interest is the volume of Anixa Biosciences shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 421,900 shares of ANIX short. 1.38% of Anixa Biosciences' shares are currently sold short. Learn More on Anixa Biosciences' current short interest. What is a good short interest ratio for Anixa Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANIX shares currently have a short interest ratio of 6.0. Learn More on Anixa Biosciences's short interest ratio. What is a good short interest percentage for Anixa Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.38% of Anixa Biosciences' floating shares are currently sold short. Is Anixa Biosciences' short interest increasing or decreasing? Anixa Biosciences saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 421,900 shares, a decline of 28.9% from the previous total of 593,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Anixa Biosciences' float size? Anixa Biosciences currently has issued a total of 32,180,000 shares. Some of Anixa Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Anixa Biosciences currently has a public float of 30,550,000 shares. How does Anixa Biosciences' short interest compare to its competitors? 1.38% of Anixa Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Anixa Biosciences: Enzo Biochem, Inc. (1.31%), Psychemedics Co. (0.31%), OpGen, Inc. (0.19%), C4 Therapeutics, Inc. (8.29%), Valneva SE (0.06%), Organogenesis Holdings Inc. (12.59%), 4D Molecular Therapeutics, Inc. (17.69%), MeiraGTx Holdings plc (2.12%), Akebia Therapeutics, Inc. (6.80%), Canopy Growth Co. (9.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Anixa Biosciences stock? Short selling ANIX is an investing strategy that aims to generate trading profit from Anixa Biosciences as its price is falling. ANIX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anixa Biosciences? A short squeeze for Anixa Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ANIX, which in turn drives the price of the stock up even further. How often is Anixa Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANIX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ENZ Short Squeeze PMD Short Squeeze OPGN Short Squeeze CCCC Short Squeeze VALN Short Squeeze ORGO Short Squeeze FDMT Short Squeeze MGTX Short Squeeze AKBA Short Squeeze CGC Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANIX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anixa Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
